Related Topics
Malaria expert predicts vaccine will spur innovation
In October, the World Health Organization (WHO) for the first time recommended a broad rollout of a vaccine that protects against Plasmodium falciparum, the deadliest malaria parasite globally and the most prevalent in Africa.
WHO’s historic recommendation for malaria vaccine spurs hope
The long and at times faltering fight against malaria hit a turning point this week when the World Health Organization (WHO) recommended a broad rollout of a vaccine that protects against Plasmodium falciparum, the deadliest malaria parasite globally…

Flaminia Catteruccia named Howard Hughes Medical Institute investigator
For immediate release: Thursday, September 23, 2021 Boston, MA ─ The Howard Hughes Medical Institute (HHMI) has named Flaminia Catteruccia, professor of immunology and infectious diseases at Harvard T.H. Chan School of Public Health, as one of 33 new…

What will it be like when COVID-19 becomes endemic?
In a Q&A, Yonatan Grad, Melvin J. and Geraldine L. Glimcher Associate Professor of Immunology and Infectious Diseases, discusses what endemic COVID-19 will look like.

Accumulation of infected red blood cells in the adipose tissue is essential for development of cerebral malaria
Findings point to potential treatments and diagnostics for the often untreatable disease For immediate release: Thursday, April 15, 2021 Boston, MA – White adipose tissue (WAT), or white fat, plays a fundamental role in the development of cerebral…

Multiple blood meals for mosquitoes can speed development of malaria-causing parasites
An additional feeding on human blood by a mosquito infected with Plasmodium falciparum, the parasite that causes malaria, can accelerate the development of the parasite and increase the potential for transmission to humans, according to new research led…
How China vanquished malaria—and what African countries can learn from the experience
December 16, 2020 – In 2010, China announced one of its most ambitious undertakings in public health: It planned to eliminate indigenous cases of malaria within a decade. The disease had a long and lethal history in the country—it’s…

Significant gaps in care persist for children diagnosed with malaria in sub-Saharan Africa
Children diagnosed with malaria in nine sub-Saharan African often did not receive recommended care, and as many as 20% of children diagnosed with malaria in these countries received no antimalarial at all, according to new research from Harvard…
Bridging the Know-Do Gap
Ariadne Labs’ Better Evidence program brings the most up-to-date clinical knowledge to health care providers in resource-poor countries.

A Better Insect Repellent
Abraar Karan, MPH ’17, wants to launch a long-lasting repellent in countries suffering from malaria and other vector-borne diseases.
